PRELIMINARY-STUDY FOR APPLICATION OF ANTI-ALPHA-FETOPROTEIN MONOCLONAL-ANTIBODY TO BORON-NEUTRON CAPTURE THERAPY

被引：0

作者：

TAKAHASHI, T ^{[1
]}

FUJII, Y ^{[1
]}

FUJII, G ^{[1
]}

NARIUCHI, H ^{[1
]}

机构：

[1] UNIV TOKYO,INST MED SCI,DEPT ALLERGOL,MINATO KU,TOKYO 108,JAPAN

来源：

JAPANESE JOURNAL OF EXPERIMENTAL MEDICINE | 1987年 / 57卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：83 / 91

页数：9

共 50 条

[41] Boron neutron capture therapy for head and neck cancer: Relevance of nuclear-cytoplasmic volume ratio and anti-tumor effect. -A preliminary report-
Aihara T.
Hiratsuka J.
Kamitani N.
Nishimura H.
Ono K.
Applied Radiation and Isotopes, 2020, 163
[42] Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: An experimental study that supports a potential new application of BNCT
Hughes, A. Monti
Heber, E. M.
Pozzi, E.
Nigg, D. W.
Calzetta, O.
Blaumann, H.
Longhino, J.
Nievas, S. I.
Aromando, R. F.
Itoiz, M. E.
Trivillin, V. A.
Schwint, A. E.
APPLIED RADIATION AND ISOTOPES, 2009, 67 (7-8) : S313 - S317
[43] RGD Peptide-Conjugated Dodecaborate with the Ga-DOTA Complex: A Preliminary Study for the Development of Theranostic Agents for Boron Neutron Capture Therapy and Its Companion Diagnostics
Mishiro, Kenji
Imai, Sayaka
Ematsu, Yuki
Hirose, Katsumi
Fuchigami, Takeshi
Munekane, Masayuki
Kinuya, Seigo
Ogawa, Kazuma
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (24) : 16741 - 16753
[44] Forensic Application of Monoclonal Anti-Human Glycophorin A Antibody in Samples from Decomposed Bodies to Establish Vitality of the Injuries. A Preliminary Experimental Study
Baldari, Benedetta
Vittorio, Simona
Sessa, Francesco
Cipolloni, Luigi
Bertozzi, Giuseppe
Neri, Margherita
Cantatore, Santina
Fineschi, Vittorio
Aromatario, Mariarosaria
HEALTHCARE, 2021, 9 (05)
[45] PHASE-I/II TRIAL OF INTERFERON-ALPHA (RHUIFN-ALPHA-2A) IN COMBINATION WITH AN ANTI-GD3 MONOCLONAL-ANTIBODY (R24) IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA - PRELIMINARY-RESULTS
MURTHY, S
BUKOWSKI, RM
BARNA, B
CAULFIELD, M
TUBBS, R
VALENZUELA, R
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 387 - 387
[46] Prolonged administration of anti-interleukin-2 receptor monoclonal antibody therapy for severe steroid-refractory acute graft versus host disease: Preliminary report of a pilot study.
Soumelis, V
Delarue, R
Benettaib, B
Hirsch, I
Varet, B
Buzyn, A
BLOOD, 2002, 100 (11) : 444B - 444B
[47] Prolonged administration of anti-Interleukin-2 receptor monoclonal antibody therapy for severe steroid-refractory acute graft-versus-host disease: preliminary report of a pilot study
Soumelis, V
Delarue, R
Hirsch, I
Benettaib, B
Hermine, O
Besson, C
Varet, B
Buzyn, A
BONE MARROW TRANSPLANTATION, 2003, 31 : S141 - S141
[48] A PHASE 2 STUDY OF MULTIPLE SUBCUTANEOUS DOSES OF LY2439821, AN ANTI-IL-17 MONOCLONAL ANTIBODY, IN PATIENTS WITH RHEUMATOID ARTHRITIS IN TWO POPULATIONS: NAIVE TO BIOLOGIC THERAPY OR INADEQUATE RESPONDERS TO TUMOR NECROSIS FACTOR ALPHA INHIBITORS
Genovese, M.
Greenwald, M.
Cho, C. -S.
Berman, A.
Jin, L.
Cameron, G.
Wang, L.
Xie, L.
Braun, D.
Berclaz, P. -Y.
Banerjee, S.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 59 - 59
[49] A Phase 2 Study of Multiple Subcutaneous Doses of LY2439821, An Anti-IL-17 Monoclonal Antibody, in Patients with Rheumatoid Arthritis in Two Populations: Naive to Biologic Therapy or Inadequate Responders to Tumor Necrosis Factor Alpha Inhibitors.
Genovese, Mark C.
Greenwald, Maria W.
Cho, Chul Soo
Berman, Alberto
Jin, Ling
Cameron, Gregory
Xie, Li
Braun, Daniel
Banerjee, Subhashis
Warner, Laura
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S1017 - S1017
[50] Combined recombinant humanized anti-PD-1 monoclonal antibody (JS']JS001) and nab-paclitaxel/gemcitabine (AG) as the first-line therapy for patients with advanced pancreatic adenocarcinoma: Preliminary results of an open-label, phase Ib/II clinical study.
Cheng, Ke
Li, Zhiping
Cao, Dan
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)

← 1 2 3 4 5 →